Literature DB >> 17066467

Etoposide-related secondary acute myeloid leukemia (t-AML) in hemophagocytic lymphohistiocytosis.

Shinsaku Imashuku1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17066467     DOI： 10.1002/pbc.21082

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  5 in total

1.  Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.

Authors:  Kai Lehmberg; Kim E Nichols; Jan-Inge Henter; Michael Girschikofsky; Tatiana Greenwood; Michael Jordan; Ashish Kumar; Milen Minkov; Paul La Rosée; Sheila Weitzman
Journal:  Haematologica       Date:  2015-08       Impact factor: 9.941

2.  Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.

Authors:  Jonathan P McNally; Scott H Millen; Vandana Chaturvedi; Nora Lakes; Catherine E Terrell; Eileen E Elfers; Kaitlin R Carroll; Simon P Hogan; Paul R Andreassen; Julie Kanter; Carl E Allen; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Joyce; David A Hildeman; Jonathan D Katz; Michael B Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.

Authors:  Theodore S Johnson; Catherine E Terrell; Scott H Millen; Jonathan D Katz; David A Hildeman; Michael B Jordan
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

4.  Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations.

Authors:  Maciej Machaczka; Monika Klimkowska; Samuel C C Chiang; Marie Meeths; Martha-Lena Müller; Britt Gustafsson; Jan-Inge Henter; Yenan T Bryceson
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

5.  Eliminating encephalitogenic T cells without undermining protective immunity.

Authors:  Jonathan P McNally; Eileen E Elfers; Catherine E Terrell; Eli Grunblatt; David A Hildeman; Michael B Jordan; Jonathan D Katz
Journal:  J Immunol       Date:  2013-11-25       Impact factor: 5.422
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.